Peptide record

TPDB06783

Halictine 1 Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
12 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06783
Halictine 1
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF AFP-GFuse Antifungipept CAFPdb APD_complete APD_hemolytic Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 12-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GMWSKILGHLIR
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C65H107N19O14S1
ANDCEQFPTYV
GIL
1410.74
11.49
3
0
6
+2
0.19
0.367
130.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
5500
3.90
1
Residue Composition
number
0
A
1
R
0
N
0
D
0
C
0
E
0
Q
2
G
1
H
2
I
2
L
1
K
1
M
0
F
0
P
1
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 2 H: 1 I: 2 L: 2 K: 1 M: 1 F: 0 P: 0 S: 1 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
12 reviewed residue count
C65H107N19O14S1 sequence-only estimate (linear, free termini)
1410.74 sequence-only estimate (linear, free termini)
11.49 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
0.19 sequence-only estimate (linear, free termini)
0.367 sequence-only estimate (linear, free termini)
Free Activity
L Activity
Not Available Activity
Free Activity
Anticancer Activity
venom, the eusocial bee, Halictus sexcinctus Activity
Evidence Records 7 records
Evidence 1 Activity

Activity

Not Available
Anticancer

Target

Not Available
Not Available
Not Available

Assay & Model

Not Available
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2010

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

LC50
Hemolysis
82 µM
[Ref.20198492] LC50=82µM against rat red blood cells

Target

rat red blood cells

Source & Reference

Hemolytik APD_complete APD_hemolytic PD_Hemolysis
DRAMP4
Amino Acids. 2010 Aug 39(3):763-75.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 3 Activity

Activity

50% Hemolysis
Toxicity
82 µM
Hemolytic Cytotoxic
50% Hemolysis | 82 | µM | target cell: Rat erythrocytes

Target

Rat erythrocytes

Source & Reference

NA
DBAASP
Evidence 4 Activity

Activity

IC50
Toxicity
48±19 µM
Cytotoxic
IC50 | 48±19 | µM | target cell: Human umbilical vein endothelial cells HUVEC

Target

Human umbilical vein endothelial cells HUVEC

Source & Reference

NA
DBAASP
Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells. | Peptides | 2012
Evidence 5 Activity

Activity

IC50
Toxicity
38±2 µM
Cytotoxic
IC50 | 38±2 | µM | target cell: Rat epithelial cells IEC-6, CRL-1592

Target

Rat epithelial cells IEC-6, CRL-1592

Source & Reference

NA
DBAASP
Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells. | Peptides | 2012
Evidence 6 Activity

Activity

LC50
Toxicity
82 µM
Hemolytic
Hemolytic_activity: [Ref.20198492] LC50=82µM against rat red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Amino Acids. 2010 Aug 39(3):763-75.
Evidence 7 Hemolysis

Activity

82 µM
LC50
[Ref.20198492] LC50=82µM against rat red blood cells
Hemolysis

Target

rat red blood cells

Source & Reference

APD_complete APD_hemolytic PD_Hemolysis
Amino Acids. 2010 Aug 39(3):763-75.
DRAMP4
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.